BioSpace News Archive

Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced results from preclinical studies demonstrating the potential of Codiak’s proprietary engineered exosome therapeutic, exoSTING.

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the Stifel 2018 Healthcare Conference on Tuesday, November 13,

Precera Bioscience, Inc. (“Precera”) announces the publication of Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications in JAMA Open Network on November 2, 2018,

This week, Dr. Neil Olson, Dean of St. George’s University School of Veterinary Medicine, announced that the American Veterinary Medical Association Council on Education has renewed the school’s full accreditation for the maximum term of seven years, through 2025.

Decision Resources Group is pleased to introduce CoPay Accumulator Threat Assessor as its latest product offering.

The March of Dimes Database for Preterm Birth Research, announced today in the journal Scientific Data, is already one of the most important innovative new tools for collaborative research on preterm birth, which affects 15 million babies worldwide each year. Now it’s ready to become an engine of discovery, March of Dimes says.

Company launches new brand and website and celebrates 20 million medication order milestone

The Phase 1 trial of FOR46 in metastatic castration-resistant prostate cancer is planned to launch by the end of the year.

Biotechs embrace digital disruption as fee-for-value permeates the industry

The “2018 Southwest Sports Marketing Report,” crafted and commissioned by leading marketing services agency LAVIDGE, reveals insights about consumer spending choices in this fast-evolving space.